-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Arcturus Therapeutics Holdings Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2021 to 2023.
- Arcturus Therapeutics Holdings Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 27.1M shares, a 1.84% increase year-over-year.
- Arcturus Therapeutics Holdings Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 26.6M shares, a 1.72% decline from 2022.
- Arcturus Therapeutics Holdings Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 27.1M shares, a 2.95% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)